Screener
Ginkgo Bioworks DNA Deferred Tax Assets and Other Non-Current Assets
Deferred Tax Assets and Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Ginkgo Bioworks in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The source filing: Ginkgo Bioworks’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:09 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054298
| Line item | As of June 30, 2026 | As of December 31, 2025 |
|---|---|---|
| Investments | 14,775 | 15,066 |
| Equity method investments | 7,615 | — |
| Intangible assets, net | 44,387 | 53,482 |
| Other non-current assets | 1,323 | 9,029 |
| Assets held for sale | — | 3,854 |
| Total assets | $990,046 | $1,119,696 |
| Liabilities and Stockholders’ Equity | ||
| Current liabilities: |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Ginkgo Bioworks's deferred tax assets and other non-current assets?
- Ginkgo Bioworks (DNA) reported deferred tax assets and other non-current assets of $1.32M in Q2 2026.
- How has Ginkgo Bioworks's deferred tax assets and other non-current assets changed year-over-year?
- Ginkgo Bioworks's deferred tax assets and other non-current assets decreased by 97.2% year-over-year, from $47.02M to $1.32M.
- What is the long-term trend for Ginkgo Bioworks's deferred tax assets and other non-current assets?
- Over 5 years (2020 to 2025), Ginkgo Bioworks's deferred tax assets and other non-current assets has grown at a 10.0% compound annual growth rate (CAGR), from $5.6M to $9.03M.
- What does deferred tax assets and other non-current assets mean?
- Combined balance of non-current deferred tax assets and other miscellaneous non-current assets.
Ask your AI about Ginkgo Bioworks's deferred tax assets and other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude